Beyond Air (XAIR) stock whipsaws after NeuroNOS deal — premarket drop follows 150% rally
Beyond Air shares fell 16.4% to $1.83 in premarket trading Wednesday after soaring 150% on Tuesday, with volume hitting 408.6 million shares. The drop followed news that XTL Biopharmaceuticals will acquire 85% of Beyond Air’s NeuroNOS unit in a deal worth up to $32.5 million in cash and milestones.
